As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.
6 Analysts have issued a Profound Medical Corp forecast:
6 Analysts have issued a Profound Medical Corp forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 14 14 |
59%
59%
|
|
| Gross Profit | 10 10 |
87%
87%
|
|
| EBITDA | -42 -42 |
29%
29%
|
|
| EBIT (Operating Income) EBIT | -42 -42 |
28%
28%
|
|
| Net Profit | -39 -39 |
25%
25%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.
| Head office | Canada |
| CEO | Arun Menawat |
| Employees | 142 |
| Founded | 2008 |
| Website | profoundmedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


